Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepa Jagadeesh

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Blood Advances|June 23, 2023
Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease preventionBetty K Hamilton, Lisa A Rybicki, Hong Li, et al.
Haematologica|July 13, 2023
Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter studySwaminathan P Iyer, Auris Huen, Weiyun Z Ai, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 7, 2017
Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma, a Single-Institution ExperienceYazeed Sawalha, Brian T Hill, Lisa A Rybicki, et al.
American Journal of Hematology|March 25, 2024
BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantationRobert Stuver, Agrima Mian, Samantha Brown, et al.
Archives of Pathology & Laboratory Medicine|April 26, 2022
Best Practices in CD30 Immunohistochemistry Testing, Interpretation, and Reporting: An Expert Panel ConsensusAlejandro A Gru, Megan S Lim, Ahmet Dogan, et al.
Bone Marrow Transplantation|October 31, 2018
Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantationSagar S Patel, Lisa A Rybicki, Donna Corrigan, et al.
Transplantation and Cellular Therapy|March 2, 2024
A US Multicenter Collaborative Study on Outcomes of Hematopoietic Cell Transplantation in Hepatosplenic T-Cell LymphomaMuhamad Alhaj Moustafa, Jeremy L Ramdial, Athanasios Tsalatsanis, et al.
Hematology/Oncology and Stem Cell Therapy|December 28, 2019
Influence of major histocompatibility complex class I chain-related gene A polymorphisms on cytomegalovirus disease after allogeneic hematopoietic cell transplantationSagar S Patel, Lisa A Rybicki, Melissa Yurch, et al.
Transplantation and Cellular Therapy|June 10, 2026
Neighborhood socioeconomic disadvantage and distance from treatment center do not impact survival outcomes of patients with non-Hodgkin lymphoma and multiple myeloma treated with CAR T-cell therapiesAgrima Mian, Rafaella Litvin, Danai Dima, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 24, 2017
Music Therapy for Symptom Management After Autologous Stem Cell Transplantation: Results From a Randomized StudyDebbie Bates, Brian Bolwell, Navneet S Majhail, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Blood Advances|June 23, 2023
Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease preventionBetty K Hamilton, Lisa A Rybicki, Hong Li, et al.
Haematologica|July 13, 2023
Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter studySwaminathan P Iyer, Auris Huen, Weiyun Z Ai, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 7, 2017
Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma, a Single-Institution ExperienceYazeed Sawalha, Brian T Hill, Lisa A Rybicki, et al.
American Journal of Hematology|March 25, 2024
BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantationRobert Stuver, Agrima Mian, Samantha Brown, et al.
Archives of Pathology & Laboratory Medicine|April 26, 2022
Best Practices in CD30 Immunohistochemistry Testing, Interpretation, and Reporting: An Expert Panel ConsensusAlejandro A Gru, Megan S Lim, Ahmet Dogan, et al.
Bone Marrow Transplantation|October 31, 2018
Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantationSagar S Patel, Lisa A Rybicki, Donna Corrigan, et al.
Transplantation and Cellular Therapy|March 2, 2024
A US Multicenter Collaborative Study on Outcomes of Hematopoietic Cell Transplantation in Hepatosplenic T-Cell LymphomaMuhamad Alhaj Moustafa, Jeremy L Ramdial, Athanasios Tsalatsanis, et al.
Hematology/Oncology and Stem Cell Therapy|December 28, 2019
Influence of major histocompatibility complex class I chain-related gene A polymorphisms on cytomegalovirus disease after allogeneic hematopoietic cell transplantationSagar S Patel, Lisa A Rybicki, Melissa Yurch, et al.
Transplantation and Cellular Therapy|June 10, 2026
Neighborhood socioeconomic disadvantage and distance from treatment center do not impact survival outcomes of patients with non-Hodgkin lymphoma and multiple myeloma treated with CAR T-cell therapiesAgrima Mian, Rafaella Litvin, Danai Dima, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 24, 2017
Music Therapy for Symptom Management After Autologous Stem Cell Transplantation: Results From a Randomized StudyDebbie Bates, Brian Bolwell, Navneet S Majhail, et al.
Pageof 10